[Renal cell carcinoma in children]

M E Cela De Julián1, A Casanova Morcillo, J Vázquez Estévez

  • 1Sección de Oncohematología Pediátrica, Hospital General Universitario Gregorio Marañón, Madrid, España. la.llerueb@hsvo.insalud.es

Insights

Pediatric renal cell carcinoma (RCC) is rare, necessitating clear communication for diagnosis and follow-up. Early detection and complete surgical resection are key prognostic factors for this uncommon childhood cancer.

Area of Science:

  • Pediatric Oncology
  • Urologic Oncology

Background:

  • Renal cell carcinoma (RCC) is uncommon in children, with distinct behaviors compared to adult presentations.
  • Established treatment protocols for adult RCC, primarily surgical resection, may not directly translate to pediatric cases.
  • The efficacy of chemotherapy and radiotherapy for metastatic pediatric RCC remains poorly defined.

Observation:

  • A retrospective review of a single pediatric institution's experience over twenty years identified only three cases of pediatric RCC.
  • Detailed clinical features and therapeutic strategies employed for these three pediatric patients are presented.
  • The study highlights the importance of clinical suspicion for RCC in children over five with renal masses, differentiating it from Wilms' tumor.

Findings:

  • Staging and complete surgical resection appear to be significant prognostic indicators in pediatric renal cell carcinoma.
  • The limited data underscore the rarity of this malignancy in the pediatric population.
  • Current treatment approaches for advanced or metastatic pediatric RCC require further investigation and standardization.

Implications:

  • Multicenter collaboration is crucial for standardizing treatment protocols for advanced-stage pediatric RCC.
  • Further research is needed to define the role of novel therapies, including allogeneic stem cell transplantation, in managing metastatic pediatric RCC.
  • Improved diagnostic and therapeutic strategies are essential for optimizing outcomes in children diagnosed with renal cell carcinoma.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...